Navigation Links
Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
Date:8/27/2007

EDISON, N.J., Aug. 27 /PRNewswire/ -- Heritage Pharmaceuticals Inc. ("Heritage") and Ipca Laboratories Ltd. ("Ipca") announced today that they have entered in to a strategic alliance for the development, supply and marketing of generic pharmaceutical products for the U.S. prescription drug market. Under the Agreement, Ipca shall develop and register selected products for U.S. ANDA submission and Heritage retains sales and marketing rights to such products. The parties shall share net profits from the sales proceeds post-launch.

Commenting on the Agreement, Heritage President & CEO, Jeffrey Glazer, stated, "Our agreement with Ipca represents yet another important strategic partnership with an emerging, low cost developer and supplier of active ingredients and finished goods. These types of agreements enable Heritage to leverage our business model of strategic outsourcing to obtain a "virtually vertical" supply chain of quality generic products as we continue to expand our product offerings."

Heritage Pharmaceuticals Inc. is an emerging generic pharmaceutical company engaged in the acquisition, licensing, development, marketing, sale and distribution of generic pharmaceutical products for the global prescription drug markets. Heritage launched its U.S. label in 2006 and currently markets 3 products over 10 SKU's. The Company will continue to introduce its acquired multi-source generic product line during 2007-08 following its tradition of premier quality, value and service in generics.

Ipca Laboratories Ltd. is a fast growing fully integrated pharmaceutical company based in Mumbai, India engaged in the manufacturing and marketing of a range of pharmaceuticals with a thrust on international business. Ipca exports its Active Pharmaceutical Ingredients and Finished Dosages to over 110 countries across the globe, which contributed about 53% of the Company's total global income of $227mm in the financial year 2006-07. It has a strong focus on inter
'/>"/>

SOURCE Heritage Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. NanoRite Innovation Center opens with small science, big promise
2. UW-Madison to receive $125M for bioenergy research center
3. WARF enters licensing agreements for stem cell products
4. Internet-enabled niche markets take center stage
5. Virent enters agreement with Shell Oil unit to make hydrogen with biomass
6. TomoTherapy opens technical training center
7. Stem cell and regenerative medicine center to aid education and commerce
8. Mega-Metro Center may go beyond Chicago and Wisconsin
9. Software company enters health space with RFID solutions on hold
10. Former Fiserv exec to enter Business Hall of Fame
11. Berbee to expand at New Venture Center

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...-Asia/ -- The world is going through,extraordinary...part of many,businesses and industries. It turns o...mune to the economic downturn, because illness doe...of the difficult times this year, the pharmaceutic...p;D center in Shanghai, the largest of,its kind in...
(Date:12/1/2009)...swire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nas...the fourth quarter ended December 31, 2009 of appr...n for the fourth quarter of 2008. Included in four...llment payments of $12.5 million from Alexion. Al...ne-time $1.8 million payment from Genentech for th...
(Date:12/1/2009).../ -- Harvest Technologies Corp. ( www.harvesttech....nsored 60-patient clinical trial conducted at Sri ... the company,s BMAC System to treat patients with ...Sri Ramachandra Medical Center is a Harvard Medica...ennai, India and one of the largest private health...
(Date:12/1/2009)...e/ -- Expanding its European reach for bacterial p...ppointed Lake Chemicals and Minerals of England as...gham, England. ,, Osprey breeds trillions of b...aste water, and environmental markets. Its bacteri...and clean up industrial and marine spills. In agri...
Breaking Biology Technology:Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3
...llars, QUEBEC CITY, Nov. 13 /PRNewswire-FirstCall...Z), a global biopharmaceutical company focused on,...al and operating results,for the third quarter end...ights, - Appointment on September 1, 2008, of Jue...na Zentaris, replacing Juergen Ernst who had been ...
...eduction in loss for the quarter, SAN JOSE, Calif...lletin Board: EROX) ("HPS" or "the Company") today...months ended September 30,2008. For the three mont...f,$262,000 represented a 10% increase from the rev...sulted in a net loss of $30,000 ($.01 per share),a...
...s professor Apparao Rao and his team are researchi...to read and alert us to toxic chemicals or gases i...nd the potential is there for real-time chemical a...ven at home. , "The ability to build extremely sm...ve only seen so far in science-fiction movies," Ra...
Other Biology Technology:AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results 2AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results 3AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results 4AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results 5AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results 6AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results 7AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results 8AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results 9Human Pheromone Sciences Announces Third Quarter Results 2Human Pheromone Sciences Announces Third Quarter Results 3Human Pheromone Sciences Announces Third Quarter Results 4Clemson researchers advance nanoscale electromechanical sensors 2
(Date:12/2/2009)...a cancer-free status did not prompt people partici... lung-cancer screening program to pick up their ci...shed in Cancer Epidemiology, Biomarkers & Prevent...ncer Research. The December issue contains a speci...ate widespread concern in the lung screening commu...
(Date:12/2/2009)...eanut butter, and other foods have done more than ...ty. They also are quietly fueling a boom in the ma...food safety regulations. That,s the topic of the t...cal & Engineering News , (C&EN) ACS, weekly newsma...and Senior Correspondent Marc Reisch point out tha...
(Date:12/2/2009)...of undergraduate students from Stevens Institute o...poster contest hosted by the International Society...nual contest highlights the research conducted by ...nnual Meeting in San Diego, Calif. , The winning...e Ligament Tensioning Device," was presented by Aa...
Breaking Biology News(10 mins):Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2Delcath Systems Announces Completion of Public Offering 6385 1Delcath Systems Announces Completion of Public Offering 6385 2Scientists find molecular trigger that helps prevent aging and disease 61643 1Scientists find molecular trigger that helps prevent aging and disease 61643 2Scientists find molecular trigger that helps prevent aging and disease 61643 3New on off switch triggers and reverses paralysis in animals with a beam of light 10798 1
...ns Hopkins researchers have found that two genes a...ded for proper cell division. They report their fi... The researchers discovered that the two genes are..., raising the possibility that interfering with th...ell division found in cancers. Mutations in the ge...
...anoma is a particularly deadly form of skin cancer...e Moffitt Cancer Center & Research Institute a...romising new therapy that prompts the immune syste...This is a milestone clinical trial because it is t...o deliver plasmid DNA in a gene therapy study in h...
...ce 1976 the Ebola virus has caused some lethal hum...ates that humans do not become directly contaminat... still unknown, but from infected carcasses of chi...esults have come from work conducted over the past...s (1) to shed light on the virus,s propagation pat...
Other Biology News:Pair of cancer genes found to drive both cell migration and division 2Researchers test new therapy for advanced melanoma 2Ebola virus: from wildlife to dogs 2Ebola virus: from wildlife to dogs 3Ebola virus: from wildlife to dogs 4
Anti-G Protein Gi-alpha-1 Monoclonal Antibody, Unconjugated, Clone R4 from CHEMICON
Anti-VEGF Receptor-2 (FLK-1, KDR), phospho (Tyr996) Antibody, Unconjugated from CHEMICON
Rat IgG2b Clone: A95-1, Allophycocyanin Conjugated/Tagged from BD Biosciences Pharmingen
Mouse Oligodendrocyte Differentiation Kit from R&D Systems
Biology Products: